Verily, a subsidiary of Google parent company Alphabet, has received FDA clearance for the electrocardiogram (ECG) feature in its Study Watch, the company announced.

Kaia Health, a digital therapeutics company based in Munich, Germany, has raised $10 million in a Series A funding round for its apps that use AI and motion-tracking technology to manage chronic back pain and chronic obstructive pulmonary disease (COPD), according to a report by VentureBeat.

The HHS Office of the Chief Technology Office and President Innovation Fellows have completed a 14-week tech challenge that encouraged teams to create digital tools using federal data and emerging technologies—like AI—to help address several challenges in healthcare.

All signs point to technology giant Apple continuing its dive into the healthcare space with new services or devices. With its recent foray into health monitoring through its Apple Watch, the company is poised to make a splash in other areas, Fast Company predicted.

Facebook is providing $7.5 million in initial funding over five years to help establish an independent research center focused on the ethics of AI.

The FDA is fast-tracking efforts to produce an over-the-counter version of naloxone, a life-saving drug which can reverse an opioid overdose. Current FDA-approved versions of naloxone require a prescription, creating a barrier of use for some.

Healthcare, senior care and mental health diagnosis and treatment are among several industries expected to be “revolutionized” by AI, according to a report by Forbes.

A professor at Virginia Tech is gearing up for a four-year study that will use machine-learning techniques to help physicians decrease the number of deaths from traumatic brain injuries (TBIs).